Tirzepatide, sold under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for obesity), is one of the most clinically significant medications to enter the weight management space in decades. As a dual GIP and GLP-1 receptor agonist, it targets two hormone pathways simultaneously, producing weight loss outcomes that have reached up to 22 percent of total body weight in clinical trials. For many patients, knowing how to use tirzepatide at home safely is the first pra

You were losing steadily. The appetite suppression was working, the scale was moving, and the results felt almost effortless compared to everything you had tried before. Then, somewhere around month four or five, it stopped. The number on the scale has not changed in three weeks. Maybe four. You are still injecting on schedule, you have not changed your diet dramatically, and you are starting to wonder: has tirzepatide stopped working for me? It is one of the most common ques